Prevention of transfusion-associated graft-versus-host disease
- PMID: 7910356
- DOI: 10.1016/s0140-6736(94)92503-8
Prevention of transfusion-associated graft-versus-host disease
Comment on
-
Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group.Lancet. 1994 Mar 19;343(8899):700-2. doi: 10.1016/s0140-6736(94)91580-6. Lancet. 1994. PMID: 7907679
Similar articles
-
Irradiation in the prevention of transfusion associated graft-versus-host disease.Arch Dis Child. 1995 Nov;73(5):388-9. doi: 10.1136/adc.73.5.388. Arch Dis Child. 1995. PMID: 8554351 Free PMC article. Review. No abstract available.
-
Prevention of transfusion-associated graft-versus-host disease: selection of an adequate dose of gamma radiation.Transfusion. 1993 Feb;33(2):125-7. doi: 10.1046/j.1537-2995.1993.33293158043.x. Transfusion. 1993. PMID: 8430450
-
Determination of the radiation dose on blood components to prevent post-transfusional graft-vs-host reaction.Haematologica. 1983 Sep-Oct;68(5):573-80. Haematologica. 1983. PMID: 6416937 No abstract available.
-
Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.Transfusion. 2018 Jun;58(6):1506-1515. doi: 10.1111/trf.14589. Epub 2018 Apr 2. Transfusion. 2018. PMID: 29607502
-
Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components.Semin Hematol. 2001 Oct;38(4 Suppl 11):34-45. doi: 10.1016/s0037-1963(01)90122-2. Semin Hematol. 2001. PMID: 11727284 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical